High blood pressure treatment in pregnancy is safe and could reduce mother’s risks
PROTECTED CONTENT
If you’re a current subscriber, log in below. If you would like to subscribe, please click the subscribe tab above.
Username and Password Help
Please enter your email and we will send your username and password to you.
American Heart Association News
Treating high blood pressure during pregnancy is safe and may be helpful at lower thresholds than previously thought, a new scientific report says.
“For decades, the benefits of blood pressure treatment for pregnant women were unclear,” Dr. Vesna D. Garovic said in a news release. She led a committee of experts that reviewed and analyzed existing research. “And there were concerns about fetal well-being from exposure to antihypertensive medications.”
But the report, published Wednesday as a scientific statement from the American Heart Association in its journal Hypertension, said treatment may reduce a woman’s risk for severe high blood pressure without endangering her child.
High blood pressure, or hypertension, during pregnancy is a major cause of complications and death for mothers and their babies, and it increases women’s short- and long-term risks for cardiovascular disease. It also increases the risk for preterm delivery and low birthweight.
Among high-income countries, the U.S. has one of the highest maternal mortality rates for high blood pressure-related problems. Cardiovascular disease, including stroke and heart failure, now accounts for up to half of all maternal deaths in the U.S., where pregnancy-related stroke hospitalizations increased more than 60% from 1994 to 2011.
In the U.S., high blood pressure during pregnancy disproportionately affects women who are Black, American Indian or Alaska Native.
“Given the rising number of cases of hypertension during pregnancy, together with hypertension-related complications, the problem has become a public health crisis, particularly among women from racially and ethnically diverse backgrounds,” said Garovic, a professor of medicine at Mayo Clinic in Rochester, Minnesota.
A scientific statement is an expert analysis of current research and may inform future clinical practice guidelines. This one was written by experts in obstetrics and gynecology, maternal-fetal medicine, cardiology, nephrology, hypertension and internal medicine.
Hypertension during pregnancy is the second-leading cause of maternal death worldwide. Severe cases are associated with increased risks of heart-related complications for mothers both immediately after delivery and for years later.
Because of concerns about how medications may affect the fetus, treatment guidelines vary.
Since 2017, the AHA and the American College of Cardiology have defined high blood pressure in the general population as a systolic (top) reading of at least 130 mmHg or a diastolic (bottom) reading of at least 80 mmHg.
Most guidelines worldwide define high blood pressure during pregnancy as a reading of 140/90. In the U.S., the American College of Obstetricians and Gynecologists recommends starting treatment at 160/110. Other guidelines recommend starting treatment at 140/90.
The statement said the latest research indicates use of blood pressure-lowering medicine during pregnancy does not appear to harm fetal development. And preventing high blood pressure during pregnancy supports maternal health both during and after pregnancy. Women who have hypertension during pregnancy are more likely to develop sustained high blood pressure after pregnancy at a higher rate compared to those whose blood pressure was normal during pregnancy.
“Future clinical trials are needed to address questions about when to begin treatment for high blood pressure during pregnancy,” Garovic said. But, she said, it was “reassuring” that the statement’s comprehensive review of research showed “emerging evidence that treating high blood pressure during pregnancy is safe and effective and may be beneficial at lower thresholds than previously thought.”
Reducing severe high blood pressure may be particularly important in communities that lack resources and expertise to respond to hypertension emergencies, the statement said.
It also reinforces recent research that suggests lifestyle changes before and during pregnancy can improve maternal and fetal outcomes. For example, dietary changes before and during pregnancy can limit weight gain and improve pregnancy outcomes. And exercise during pregnancy may reduce the risk of gestational hypertension by about 30% and of preeclampsia by about 40%.
If you have questions or comments about this story, please email editor@heart.org.
Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News.
Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.
HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.
